Publication | Closed Access

Semaglutide ameliorates obesity-induced cardiac inflammation and oxidative stress mediated via reduction of neutrophil Cxcl2, S100a8, and S100a9 expression

InflammationMetabolic SyndromeObesityObesity-induced Cardiac InflammationAnti-inflammatoryS100a9 ExpressionMedicinePhysiologyImmunologyChronic InflammationInflammatory MarkerAutoimmunityPharmacologyOxidative StressHealth Sciences